The PulseCalendarExplorerLongevity Clinics MapLongevity Investors MapWearables & Nearables MapAcademyCoursesMy LearningAbout

Masters of Longevity - The Pulse

Feature21 Jul 2026

Wellness promised us an easier life, yet gave Us 14 Things to Do Before Breakfast

Recovery should make us feel better — not give us more data, decisions and routines to manage. This opinion asks when self-care became another job, and what health technology should do differently.

A visibly worried person studies a phone whose screen faces away from the viewer, surrounded by wellness devices.

Editorial Picks

More from MoL
A physician discussing evidence-based preventive care with an older patient in a consultation room

Can Doctors Be Trained for the Longevity Era?

Editorial24 Jul 2026

ApoB

ApoB: The cholesterol signal LDL can miss

Editorial07 Jul 2026

Unlabeled biologic vials in front of body-composition scan imagery

The Next Obesity-Drug Race Is About What Weight You Lose

Editorial25 Jun 2026

health tracking stress

When Health Tracking Becomes Self-Surveillance

Lifestyle Brief24 Jun 2026

midjourney female_lower_abdomen

Midjourney’s Strange Leap Into Preventive Health

News22 Jun 2026

wearables and nearables map

Wearables, Nearables, And The New Body-Data Stack

MoL Research15 Jun 2026

Trending News

Based on last 48h engagement

  1. 01Can Doctors Be Trained for the Longevity Era? (Masters of Longevity)Can Doctors Be Trained for the Longevity Era?Masters of Longevity • 24 Jul 2026
  2. 02ECT Reprograms Adult Neurons into a Youthful State (Neuroscience News)ECT Reprograms Adult Neurons into a Youthful StateNeuroscience News • 17 Jul 2026
  3. 03Recall-By-Genotype for Precision Psychiatry (Neuroscience News)Recall-By-Genotype for Precision PsychiatryNeuroscience News • 25 Jul 2026
  4. 04Reversal of protein chemical aging by enzymatic deglycation (Nature - Biotechnology)Reversal of protein chemical aging by enzymatic deglycationNature - Biotechnology • 14 Jul 2026
  5. 05Lithium and Alzheimer’s disease: what to weave of this LATTICE? (Peter Attia Blog)Lithium and Alzheimer’s disease: what to weave of this LATTICE?Peter Attia Blog • 25 Jul 2026

Upcoming Events

View calendar
  1. Longevity by Design (Santa Fe, United States)2. AUG 2026 - 6. AUG 2026Longevity by DesignRetreat - Santa Fe, USA
  2. LONGEVITY8 at Canyon Ranch Tucson (Tucson, United States)9. AUG 2026 - 13. AUG 2026LONGEVITY8 at Canyon Ranch TucsonRetreat - Tucson, USA
  3. Longevity Summit India 2026 (Mumbai, India)15. AUG 2026 - 16. AUG 2026Longevity Summit India 2026Summit - Mumbai, India
  4. 1st Annual Buck Institute Reproductive Aging Summit (Novato, United States)21. AUG 2026 · 08:30–18:001st Annual Buck Institute Reproductive Aging SummitSummit - Novato, USA
  5. Longevity Wellness Expo 2026 (Toronto, Canada)2. OCT 2026 - 4. OCT 2026Longevity Wellness Expo 2026Expo - Toronto, Canada★

Latest in Longevity

40+ high-signal longevity feeds, continuously monitored for you.

|←←→
Longevity Technology27 Jul 2026
AIAnHorn Medicines begins Phase 1 trial for new drug to prevent chemotherapy-related nerve damage (Longevity Technology)

AnHorn Medicines begins Phase 1 trial for new drug to prevent chemotherapy-related nerve damage

A news item announcing a clinical research update on a new preventative therapy for chemotherapy-related nerve damage, useful for readers tracking drug development and translational neurology.

Key takeaways
  • We are open to conversations with prospective partners and investors who share our vision.
  • First-in-class neuroprotective candidate being developed to prevent chemotherapy-induced peripheral neuropathy.
  • Notes that no approved preventive therapies currently exist.
Nature - Biotechnology27 Jul 2026
AIAn agent-guided peptide hydrogel bio-stabilizer clamps pericellular viscoelastic drift (Nature - Biotechnology)

An agent-guided peptide hydrogel bio-stabilizer clamps pericellular viscoelastic drift

Covers a materials strategy that stabilizes pericellular viscoelastic mechanics using an engineered peptide hydrogel to reduce glycation-driven mechanical drift and support tissue repair.

Key takeaways
  • This work was supported by the National Key R&D Program of China (2024YFC2418700).
  • Please note there may be errors present which affect the content, and all legal disclaimers apply.
  • We show that ViscoClamp buffers chronic glycation loading and constrains glycation-driven viscoelastic drift.
MoL Event Pick
Longevity Wellness Expo 2026 (Toronto, Canada)

Longevity Wellness Expo 2026

2. OCT 2026 - 4. OCT 2026 - Toronto, CanadaExpo

Toronto expo and conference focused on longevity, wellness, biohacking, health optimization and healthy aging products and services.

Register
Longevity Technology27 Jul 2026
AISerina advances Parkinson’s drug candidate, versatile drug delivery tech (Longevity Technology)

Serina advances Parkinson’s drug candidate, versatile drug delivery tech

Serina’s development updates on a polymer drug-delivery platform and a Parkinson’s therapy candidate, plus the company’s upcoming investor outreach.

Key takeaways
  • Serina Therapeutics will participate in the BTIG Virtual Biotechnology Conference on 28-29 July 2026.
  • POZ-apomorphine candidate intended to provide continuous dopaminergic stimulation for Parkinson’s disease.
  • Serina is a clinical-stage biotechnology company listed on NYSE American under SER and is headquartered in Huntsville.
Frontiers - Health27 Jul 2026
AIEffects of maternal exposure to an adsorbed acellular diphtheria-tetanus-pertussis (reduced-dose) combined vaccine on prenatal and postnatal development in Spra

Effects of maternal exposure to an adsorbed acellular diphtheria-tetanus-pertussis (reduced-dose) combined vaccine on prenatal and postnatal development in Sprague-Dawley rats: a preclinical study

Reports a preclinical perinatal study assessing an adsorbed reduced‑antigen DTP vaccine's safety and antibody transfer in a rat model.

Key takeaways
  • High antigen‑specific antibody titers developed in dams and were passively transferred to F1 offspring.
  • Maternal dosing produced no treatment‑related maternal systemic toxicity or adverse reproductive outcomes.
  • No negative effects were observed on offspring survival, morphology, or early neuro‑reflex milestone acquisition.